PlainRecalls
FDA Drug Moderate Class II Terminated

Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30, Rx only, Manufactured by: G&W Laboratories Inc. South Plainfield, NJ 07080, Distributed by Iroko Pharmaceuticals, LLC Philadelphia, PA 19112, NDC 42211-0102-43

Reported: March 8, 2017 Initiated: February 7, 2017 #D-0501-2017

Product Description

Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30, Rx only, Manufactured by: G&W Laboratories Inc. South Plainfield, NJ 07080, Distributed by Iroko Pharmaceuticals, LLC Philadelphia, PA 19112, NDC 42211-0102-43

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.

Details

Recalling Firm
G & W Laboratories, Inc.
Units Affected
3456 boxes
Distribution
Within United States
Location
South Plainfield, NJ

Frequently Asked Questions

What product was recalled?
Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30, Rx only, Manufactured by: G&W Laboratories Inc. South Plainfield, NJ 07080, Distributed by Iroko Pharmaceuticals, LLC Philadelphia, PA 19112, NDC 42211-0102-43. Recalled by G & W Laboratories, Inc.. Units affected: 3456 boxes.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 8, 2017. Severity: Moderate. Recall number: D-0501-2017.